University of Utah / Huntsman Cancer Institute Huntsman Cancer Cente Trials

University of Utah / Huntsman Cancer Institute Huntsman Cancer Cente	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Bajwa, Rajinder S

NCT03601442: CTL019 Out of Specification MAP for ALL or DLBCL Patients

Available

N/A

Canada, US, RoW

CTL019, tisagenlecleucel, Kymriah

Novartis Pharmaceuticals

Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL)

NCT03865589: Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

Recruiting

N/A

250

Ultrasound Elastography

Children's Mercy Hospital Kansas City, Jazz Pharmaceuticals, Nationwide Children's Hospital, Dana-Farber Cancer Institute, University of California, San Francisco, University Hospitals Cleveland Medical Center, Duke University

Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Stem Cell Transplant Complications

12/25

06/27

Lee, Catherine

FLIGHT, NCT04446182: Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

Jul 2022 - Dec 2022 : Data from part-1 of P2 FLIGHT trial for cGVHD

Terminated

Itacitinib, INCB039110, Extracorporeal Photopheresis (ECP), ECP

University of Utah, Incyte Corporation

Chronic Graft-versus-host-disease

03/22

01/23

JSP-CP-003, NCT04429191: JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Recruiting

Humanized anti-CD117 Monoclonal Antibody (JSP191), JSP191

Jasper Therapeutics, Inc.

MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML

10/23

12/23